Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Blood|December 9, 1998
Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell nicheP Gupta, T R Oegema, J J Brazil, et al.Blood|December 23, 1999
Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteinsP Gupta, T R Oegema, J J Brazil, et al.British Journal of Cancer|September 17, 2009
Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activityB J Stish, S Oh, H Chen, et al.The Journal of Biological Chemistry|February 12, 1998
Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein CA Z Dudek, C A Pennell, T D Decker, et al.British Journal of Cancer|July 27, 2007
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapyA Z Dudek, V Bodempudi, B W Welsh, et al.Cancer Gene Therapy|August 21, 2010
Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumorsV Bodempudi, J R Ohlfest, K Terai, et al.British Journal of Cancer|April 30, 2009
Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptorA Z Dudek, K Lesniewski-Kmak, N J Shehadeh, et al.British Journal of Cancer|December 5, 2013
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumoursA Khatri, B W Williams, J Fisher, et al.Pageof 1